Evogene and Compugen have both made headlines today. The two companies are related - Evogen was spun off of Compugen six years ago as an independent startup. Evogen will receive NIS 7.2 million from venture capital fund AquAgro. The ag-biotech startup develops improved plants for the agricultural and biofuel industries through [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: aquagro, compugen, evogene | No Comments »
According to webware, tech-support startup Fixya will announce a partnership with Best Buy whereby “customers wanting to perform their own fixes (or trying to dig others out of trouble) can go to the Best Buy Web site and access http://geeksquad.fixya.com from the “Customer Service” tab. They can search by product, SKU, manufacturer, or product category, [...]
Filed under: Biotech, Communications, Healthcare, Medical Devices, Medicine, Other, Software, Web 2.0 | Tagged: cleveland clinic foundation, erez gavish, fixya, intercure, mazor, perytons, resperate | No Comments »
Epix Pharmaceuticals is an Israeli biopharmaceutical established in 2000 that discovers and develops novel therapeutics using its proprietary in silico drug delivery platform. According to a press release, the company has “achieved positive results from the blinded, independent re-read of images of its novel blood pool MRA agent, Vasovist.” Previous re-read of images [...]
Filed under: Healthcare, Medical Devices, Medicine, Uncategorized | Tagged: blood pool agent, epix, michael g. kauffman, mra, uprichard, vasovist | No Comments »
Protalix BioTherapeutics announced yesterday that it received $4 million from Israel’s Office of the Chief Scientist to help it advance its clinical and pre-clinical drug development programs. The government grant program was setup to aid tech companies that have trouble seeking R&D financing from private investors.
Protalix, which was founded in 1994, intends to use [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: protalix, david aviezer, office of the chief scientist, gaucher, fabry, prgcd | No Comments »
XTL Biopharmaceuticals Ltd. is an Israeli company founded in 1993 that specializes in the acquisition, development and commercialization of therapeutics for the treatment of neuropathic pain and hepatitis C. It has just licensed its pre-clinical Hepatitis C program to San-Francisco based Presidio Pharmaceuticals Inc. which will now assume responsibility for all further R&D [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: hepatitis C, neuropathic pain, presidio, ron bentsur, trimera, xtl | No Comments »
Oramed Pharmaceuticals has successfully completed Phase 1B clinical trials of its oral insulin capsule. The Jerusalem-based company used healthy volunteers to find the optimal dosage and is now planning to commence Phase 2A trials in Israel to test safety and efficacy in Type II diabetes patients.
If approved, Oramed’s oral insulin capsule is sure to [...]
Filed under: Biotech, Healthcare, Medicine | Tagged: diabetes, diabetics, ingestible, injection, insulin, oral, oramed, pill | 1 Comment »
